Pernix Sleep, Inc. Uncategorized Contracts & Agreements

38 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
[To be separately provided to the Investor]
Pernix Sleep, Inc.
NY
2012
Sincerely, /s/ Richard W. Pascoe Richard W. Pascoe President and Chief Executive Officer
Pernix Sleep, Inc.
2011
EX-101 INSTANCE DOCUMENT
Pernix Sleep, Inc.
2011
EX-101 INSTANCE DOCUMENT
Pernix Sleep, Inc.
2011
EX-101 INSTANCE DOCUMENT
Pernix Sleep, Inc.
2011
EX-101 INSTANCE DOCUMENT
Pernix Sleep, Inc.
CA
2011
Supplement One
Pernix Sleep, Inc.
2011
Current assets
Pernix Sleep, Inc.
CA
2010
Current assets
Pernix Sleep, Inc.
2010
CO-PROMOTION AGREEMENT
Pernix Sleep, Inc.
NY
2010
Supplement One
Pernix Sleep, Inc.
2010
6,000,000 Shares
Pernix Sleep, Inc.
NY
2010
Maximize the value of Silenor. Silenor was approved by the FDA for the treatment of insomnia characterized by difficulty with sleep maintenance in March 2010. We believe that...
Pernix Sleep, Inc.
2010
Current assets
Pernix Sleep, Inc.
CA
2009
Current assets
Pernix Sleep, Inc.
CA
2009
Current assets
Pernix Sleep, Inc.
CA
2009
Number of Options
Pernix Sleep, Inc.
2009
Current assets
Pernix Sleep, Inc.
2009
Current assets
Pernix Sleep, Inc.
CA
2009
Exhibit Number
Pernix Sleep, Inc.
2009
Exhibit Number
Pernix Sleep, Inc.
2009
Maximize the value of Silenor. We have successfully completed our four Phase 3 clinical trials for Silenor in the treatment of insomnia. We designed our Phase 3 clinical program...
Pernix Sleep, Inc.
2009
Maximize the value of Silenor. We have successfully completed our four Phase 3 clinical trials for Silenor in the treatment of insomnia. We designed our Phase 3 clinical program...
Pernix Sleep, Inc.
2009
Maximize the value of Silenor. We have successfully completed our four Phase 3 clinical trials for Silenor in the treatment of insomnia. We designed our Phase 3 clinical program...
Pernix Sleep, Inc.
2009
Maximize the value of Silenor. We have successfully completed our four Phase 3 clinical trials for Silenor in the treatment of insomnia. We designed our Phase 3 clinical program...
Pernix Sleep, Inc.
CA
2009
Results of Operations and Financial Condition
Pernix Sleep, Inc.
CA
2008
Results of Operations and Financial Condition
Pernix Sleep, Inc.
CA
2008
in a clinical trial to evaluate SILENORtm in the treatment of adults (229) with chronic insomnia in a sleep laboratory setting, SILENORtm demonstrated a statistically significant...
Pernix Sleep, Inc.
CA
2008
in a clinical trial to evaluate SILENORtm in the treatment of adults (229) with chronic insomnia in a sleep laboratory setting, SILENORtm demonstrated a statistically significant...
Pernix Sleep, Inc.
2008
in a clinical trial to evaluate SILENORtm in the treatment of adults (229) with chronic insomnia in a sleep laboratory setting, SILENORtm demonstrated a statistically significant...
Pernix Sleep, Inc.
2008
in a clinical trial to evaluate SILENORtm in the treatment of adults (229) with chronic insomnia in a sleep laboratory setting, SILENORtm demonstrated a statistically significant...
Pernix Sleep, Inc.
CA
2008
in a clinical trial to evaluate SILENORtm in the treatment of adults (229) with chronic insomnia in a sleep laboratory setting, SILENORtm demonstrated a statistically significant...
Pernix Sleep, Inc.
CA
2008
SOMAXON PHARMACEUTICALS, INC.
Pernix Sleep, Inc.
CA
2007
SOMAXON PHARMACEUTICALS, INC.
Pernix Sleep, Inc.
CA
2007
W I T N E S S E T H:
Pernix Sleep, Inc.
CA
2006
Exhibit No
Pernix Sleep, Inc.
2006
SOMAXON PHARMACEUTICALS, INC.
Pernix Sleep, Inc.
CA
2006
Current assets
Pernix Sleep, Inc.
DE
2006